The Natural History and Management of Hepatic Hemangioma
Journal of Clinical Medicine · 01.09.2023 · 12 (17) · 5703
DOI: 10.3390/jcm12175703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.09.2023. Verfasst von Shigeo Maruyama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Maruyama Medical Clinic, Aioimachi 3921, Hamada 697-0034, Shimane, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Knowledge of the natural history and management of hepatic hemangiomas is lacking. The aim of this study was to investigate the natural history of hemangiomas and to elucidate the factors that determine tumor growth and optimal management.
Methods
A total of 211 adult patients were enrolled, with follow-up for more than three years. Follow-up was performed with repeated ultrasonography (US) and laboratory tests for liver function and coagulation factors (platelets, prothrombin time (PT), fibrinogen, thrombin–antithrombin III complex (TAT), D-dimer, and fibrin and fibrinogen degradation products (FDP)).
Results
Tumor size decreased in 38.9% of patients, showed no change in 31.3%, and increased in 29.8%. The incidence of a size increase was very high in patients under 40 years of age and decreased gradually with age, whereas the incidence of a size decrease increased with age and increased markedly over 60 years of age. The incidence of an increase in size decreased gradually with size enlargement, whereas the incidence of a decrease in size increased markedly with tumor size and further increased rapidly when hemangiomas became larger than 60 mm. Values of TAT, D-dimer, FDP, and Mac-2 binding protein glycosylation isomer (M2BPGi) were closely related to the change in size of hemangiomas.
Conclusions
Hemangiomas in older patients (>60 years of age) and larger tumors (>60 mm in size) had a tendency to decrease in size, resulting from the reduction in coagulation disorders and the progression of liver fibrosis. Therefore, the majority of patients with hemangiomas can be safely managed by clinical observation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Maruyama Medical Clinic, Aioimachi 3921, Hamada 697-0034, Shimane, Japan.
- St. Mary's Hospital, Nibuno 650, Himeji 670-0801, Hyogo, Japan.
- Hino Hospital, Nota 332, Hino 689-4504, Tottori, Japan.
Zitieren
APA
Maruyama, S., Matono, T., & Koda, M. (2023). The Natural History and Management of Hepatic Hemangioma. Journal of Clinical Medicine, 12(17), 5703. https://doi.org/10.3390/jcm12175703
Vancouver
Maruyama S, Matono T, Koda M. The Natural History and Management of Hepatic Hemangioma. Journal of Clinical Medicine. 2023;12(17):5703. doi:10.3390/jcm12175703
BibTeX
@article{Maruyama2023,
author = {Maruyama, Shigeo and Matono, Tomomitsu and Koda, Masahiko},
title = {The Natural History and Management of Hepatic Hemangioma},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {17},
pages = {5703},
doi = {10.3390/jcm12175703}
}
EUVIMED